2Feldman S 主编 吴新民译.神经肌肉阻滞：第1版[M].北京:科学出版社,1998.14.
3Kimura M, Kimura I, Nojima H, et al, Diabetes mellitus - induced hypersensitivity of mouse skeletal muscles to acetylcholine andsuccinylcholine. Jpn J Pharmacol, 1986, 40: 251-256.
4Minker E, Kae P, Kohai M. Effect of muscle relaxants on the motor endplate of diabetic and glucocorticoid pretreated rats. Acta Physiol Hung, 1986,67 : 257-266.
5Atallah MM, Daif AA, Saied MM, et al. Neuromuscular blocking activity of tubocurarine in patients with diabetes menitus. Br J Anaesth, 1992,68:567-569.
6Yue DK, Brooks B. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy. Med J Aust, 1993,159:76-78
7Fahim MA, Hasan MY, Alshuaib WB. Early morphological remodeling of neuromuscular junction in a murine model of diabetes. J Appl Physiol,2000, 89: 2235-2240.
二级参考文献4
1Dr. N. E. Cameron,K. C. Dines,M. A. Cotter. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats[J] 1994,Diabetologia(12):1209～1215
2E. J. Stevens,A. L. Carrington,Prof. D. R. Tomlinson. Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models[J] 1994,Diabetologia(1):43～48
3R. A. Malik,S. Tesfaye,S. D. Thompson,A. Veves,A. K. Sharma,A. J. M. Boulton,J. D. Ward. Endoneurial localisation of microvascular damage in human diabetic neuropathy[J] 1993,Diabetologia(5):454～459
4B. Bravenboer,A. C. Kappelle,F. P. T. Hamers,T. Buren,D. W. Erkelens,Prof. W. H. Gispen. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat[J] 1992,Diabetologia(9):813～817
